- cross-posted to:
- [email protected]
- [email protected]
- cross-posted to:
- [email protected]
- [email protected]
Dementia experts hail “watershed moment” after trial results for donanemab antibody treatment.
Dementia experts hail “watershed moment” after trial results for donanemab antibody treatment.
Considering that it is stated that it helped in earlier stages (before they took the patients off donanemab), I don’t think they got as far as claiming it halted the progress. From the article I mainly had the impression that it slowed it enough in some patients to show some progress in the research. Still, this is hopeful, considering the other options that have been available thus far.
That was my conclusion from the article too, but where I’m interested in is if the amyloid build up causes permanent damage to the brain, causing dementia, or with the removal of amyloid (which was never possible before) does the patient gain back anything they lost?
It seems surprising they left that answer out as it is very compelling to how the disease actually works.